{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:53:31Z","timestamp":1794707611834,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["20ZR1458900"],"award-info":[{"award-number":["20ZR1458900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["21ZR1463900"],"award-info":[{"award-number":["21ZR1463900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703867"],"award-info":[{"award-number":["81703867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81704018"],"award-info":[{"award-number":["81704018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174287"],"award-info":[{"award-number":["82174287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274386"],"award-info":[{"award-number":["82274386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biopha.2023.114319","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T06:41:01Z","timestamp":1675060861000},"page":"114319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway"],"prefix":"10.1016","volume":"160","author":[{"given":"Yiping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2155-8110","authenticated-orcid":false,"given":"Haiyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2023.114319_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) \u2013 pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.114319_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.114319_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114319_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.biopha.2023.114319_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114319_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.biopha.2023.114319_bib8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1248\/bpb.b17-00724","article-title":"AMPK-mediated regulation of lipid metabolism by phosphorylation","volume":"41","author":"Wang","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcpa.2010.11.011","article-title":"Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats","volume":"145","author":"Ha","year":"2011","journal-title":"J. Comp. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114319_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12020-014-0465-x","article-title":"Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients","volume":"49","author":"Mariani","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.biopha.2023.114319_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2017.1392264","article-title":"Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial","volume":"37","author":"Asghari","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"issue":"7241","key":"10.1016\/j.biopha.2023.114319_bib12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Canto","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2023.114319_bib13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"02","key":"10.1016\/j.biopha.2023.114319_bib15","first-page":"149","article-title":"Advantages and prospects of traditional Chinese medicine in treating nonalcoholic fatty liver disease","volume":"10","author":"Hu","year":"2015","journal-title":"WORLD Chin. Med."},{"issue":"01","key":"10.1016\/j.biopha.2023.114319_bib16","first-page":"99","article-title":"Mechanism of jiaogulan (Gynostemma Pentaphyllum) on non\u2043alcoholic fatty liver disease","volume":"36","author":"Jia","year":"2021","journal-title":"ACTA Chin. Med."},{"issue":"05","key":"10.1016\/j.biopha.2023.114319_bib17","first-page":"59","article-title":"Studies on the anti-oxidant activity and anti-aging effect of compound granules from red ginseng and sea cucumber","volume":"32","author":"Shen","year":"2020","journal-title":"GINSENG Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.114319_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102475","article-title":"Gynostemma pentaphyllum extract ameliorates high-fat diet-induced obesity in C57BL\/6N mice by upregulating SIRT1","volume":"11","author":"Lee","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/oby.20539","article-title":"Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Park","year":"2014","journal-title":"Obes. (Silver Spring)"},{"issue":"3","key":"10.1016\/j.biopha.2023.114319_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1124\/dmd.110.036723","article-title":"Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2023.114319_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112087","article-title":"Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification","volume":"189","author":"Wang","year":"2020","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114319_bib22","doi-asserted-by":"crossref","first-page":"41144","DOI":"10.1038\/srep41144","article-title":"Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2023.114319_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3736\/jintegrmed2013034","article-title":"Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis","volume":"11","author":"Song","year":"2013","journal-title":"J. Integr. Med"},{"key":"10.1016\/j.biopha.2023.114319_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2014.04.010","article-title":"Discovery, synthesis, and structure-activity relationships of 20(S)-protopanaxadiol (PPD) derivatives as a novel class of AMPKalpha2beta1gamma1 activators","volume":"79","author":"Liu","year":"2014","journal-title":"Eur. J. Med Chem."},{"issue":"03","key":"10.1016\/j.biopha.2023.114319_bib25","first-page":"65","article-title":"Optimization of active components compatibility of Jiangzhi Granule to improve NAFLD based on weighed modification method","volume":"55","author":"Liu","year":"2021","journal-title":"SH J. TCM"},{"key":"10.1016\/j.biopha.2023.114319_bib26","article-title":"Scoparone improves nonalcoholic steatohepatitis through alleviating JNK\/sab signaling pathway-mediated mitochondrial dysfunction","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.114319_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"Gomez-Lechon","year":"2007","journal-title":"Chem. Biol. Inter."},{"issue":"5","key":"10.1016\/j.biopha.2023.114319_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.114319_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155163","article-title":"Susceptibility of different mouse wild type strains to develop diet-induced NAFLD\/AFLD-associated liver disease","volume":"11","author":"Fengler","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2019.08.139","article-title":"Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice","volume":"519","author":"Inamdar","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2023.114319_bib31","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3389\/fphar.2018.01538","article-title":"20(S)-protopanaxadiol inhibits titanium particle-induced inflammatory osteolysis and RANKL-mediated osteoclastogenesis via MAPK and NF-kappaB signaling pathways","volume":"9","author":"Pan","year":"2018","journal-title":"Front Pharm."},{"issue":"45","key":"10.1016\/j.biopha.2023.114319_bib32","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.3748\/wjg.v25.i45.6607","article-title":"LB100 ameliorates nonalcoholic fatty liver disease via the AMPK\/Sirt1 pathway","volume":"25","author":"Chen","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114319_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.114319_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.114319_bib35","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.29127","article-title":"The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice","volume":"65","author":"Fan","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.114319_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41419-021-03608-9","article-title":"E3 ubiquitin ligase Grail promotes hepatic steatosis through Sirt1 inhibition","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2023.114319_bib37","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic Landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.biopha.2023.114319_bib38","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2023.114319_bib39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jgr.2017.01.012","article-title":"20S-Protopanaxadiol, an aglycosylated ginsenoside metabolite, induces hepatic stellate cell apoptosis through liver kinase B1-AMP-activated protein kinase activation","volume":"41","author":"Park","year":"2017","journal-title":"J. Ginseng Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:59:29Z","timestamp":1776772769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"alternative-id":["S0753332223001075"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114319","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114319"}}